VERTEX PHARMACEUTICALS INC / MA
VRTX
Transaktioner
1000
Köp
255
Sälj
745
Nettoinsynsflöde
-988.2 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
1000 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-08-28 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-08-28 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-08-27 | SACHS BRUCE I | Director | Sell | 6 k | 0,00 | 0 USD |
| 2026-08-27 | SACHS BRUCE I | Director | Sell | 6 k | 0,00 | 0 USD |
| 2026-07-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-02 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 519,00 | 800 k USD |
| 2026-07-02 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 524,99 | 787 k USD |
| 2026-07-02 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 519,00 | 800 k USD |
| 2026-07-02 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 524,99 | 787 k USD |
| 2026-07-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | 502,71 | 416 k USD |
| 2026-07-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | 502,71 | 416 k USD |
| 2026-06-26 | Bozic Carmen | EVP and CMO | Sell | 596 | 482,50 | 288 k USD |
| 2026-06-26 | Bozic Carmen | EVP and CMO | Sell | 596 | 482,50 | 288 k USD |
| 2026-06-18 | Bozic Carmen | EVP and CMO | Sell | 1 k | 462,17 | 471 k USD |
| 2026-06-18 | Bozic Carmen | EVP and CMO | Sell | 1 k | 462,17 | 471 k USD |
| 2026-06-15 | Bozic Carmen | EVP and CMO | Sell | 4 k | 450,00 | 1.8 mn USD |
| 2026-06-15 | Bozic Carmen | EVP and CMO | Sell | 4 k | 450,00 | 1.8 mn USD |
| 2026-06-05 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,00 | 785 k USD |
| 2026-06-05 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,00 | 785 k USD |
| 2026-06-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | 439,91 | 364 k USD |
| 2026-06-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | 439,91 | 364 k USD |
| 2026-05-29 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,00 | 888 k USD |
| 2026-05-29 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,00 | 888 k USD |
| 2026-05-15 | Bozic Carmen | EVP and CMO | Sell | 1 k | 453,45 | 614 k USD |
| 2026-05-15 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 33 | 453,45 | 15 k USD |
| 2026-05-15 | Bozic Carmen | EVP and CMO | Sell | 1 k | 453,45 | 614 k USD |
| 2026-05-15 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 33 | 453,45 | 15 k USD |
| 2026-05-12 | Bozic Carmen | EVP and CMO | Sell | 7 k | 450,00 | 3.1 mn USD |
| 2026-05-12 | Bozic Carmen | EVP and CMO | Sell | 7 k | 450,00 | 3.1 mn USD |
| 2026-05-04 | Bhatia Sangeeta N. | Director | Sell | 318 | 423,73 | 135 k USD |
| 2026-05-04 | Bhatia Sangeeta N. | Director | Sell | 318 | 423,73 | 135 k USD |
| 2026-05-01 | Bhatia Sangeeta N. | Director | Buy | 943 | 0,00 | 0 USD |
| 2026-05-01 | Garber Alan M | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 1 k | 425,02 | 469 k USD |
| 2026-05-01 | MCKENZIE DIANA | Director | Buy | 943 | 0,00 | 0 USD |
| 2026-05-01 | MCKENZIE DIANA | Director | Sell | 796 | – | – |
| 2026-05-01 | Schneider Jennifer | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Schneider Jennifer | Director | Sell | 796 | – | – |
| 2026-05-01 | Thornberry Nancy | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Thornberry Nancy | Director | Sell | 398 | – | – |
| 2026-05-01 | Upadhyay Suketu | Director | Sell | 796 | – | – |
| 2026-05-01 | Bhatia Sangeeta N. | Director | Buy | 943 | 0,00 | 0 USD |
| 2026-05-01 | Garber Alan M | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 1 k | 425,02 | 469 k USD |
| 2026-05-01 | MCKENZIE DIANA | Director | Buy | 943 | 0,00 | 0 USD |
| 2026-05-01 | MCKENZIE DIANA | Director | Sell | 796 | – | – |
| 2026-05-01 | Schneider Jennifer | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Schneider Jennifer | Director | Sell | 796 | – | – |
| 2026-05-01 | Thornberry Nancy | Director | Buy | 472 | 0,00 | 0 USD |
| 2026-05-01 | Thornberry Nancy | Director | Sell | 398 | – | – |
| 2026-05-01 | Upadhyay Suketu | Director | Sell | 796 | – | – |
| 2026-04-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 978 | 449,17 | 439 k USD |
| 2026-04-01 | Liu Joy | EVP and Chief Legal Officer | Sell | 978 | 449,17 | 439 k USD |
| 2026-03-27 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,95 | 1.1 mn USD |
| 2026-03-27 | Bozic Carmen | EVP and CMO | Sell | 2 k | 450,95 | 1.1 mn USD |
| 2026-03-13 | Bozic Carmen | EVP and CMO | Sell | 2 k | 481,79 | 1.1 mn USD |
| 2026-03-13 | Bozic Carmen | EVP and CMO | Sell | 2 k | 481,79 | 1.1 mn USD |
| 2026-03-11 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 3 k | 498,42 | 1.3 mn USD |
| 2026-03-11 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 3 k | 498,42 | 1.3 mn USD |
| 2026-03-04 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 475,30 | 1.2 mn USD |
| 2026-03-04 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 475,30 | 1.2 mn USD |
| 2026-03-02 | Liu Joy | EVP and Chief Legal Officer | Sell | 892 | 495,96 | 442 k USD |
| 2026-03-02 | Liu Joy | EVP and Chief Legal Officer | Sell | 892 | 495,96 | 442 k USD |
| 2026-02-27 | Bozic Carmen | EVP and CMO | Sell | 2 k | 480,31 | 1.1 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 400 | 479,75 | 192 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 120 | 481,50 | 58 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 240 | 482,84 | 116 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 487,13 | 1.2 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 488,27 | 1.6 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 460 | 489,32 | 225 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 490,54 | 1.3 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 949 | 491,30 | 466 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 493,29 | 1.2 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 494,33 | 1.7 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 16 k | 495,38 | 7.7 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 6 k | 496,16 | 3.0 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 496,95 | 857 k USD |
| 2026-02-27 | Bozic Carmen | EVP and CMO | Sell | 2 k | 480,31 | 1.1 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 400 | 479,75 | 192 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 120 | 481,50 | 58 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 240 | 482,84 | 116 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 487,13 | 1.2 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 488,27 | 1.6 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 460 | 489,32 | 225 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 490,54 | 1.3 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 949 | 491,30 | 466 k USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 493,29 | 1.2 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 3 k | 494,33 | 1.7 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 16 k | 495,38 | 7.7 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 6 k | 496,16 | 3.0 mn USD |
| 2026-02-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 496,95 | 857 k USD |
| 2026-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 357 | 483,36 | 173 k USD |
| 2026-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 357 | 483,36 | 173 k USD |
| 2026-02-25 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 223 | 486,35 | 108 k USD |
| 2026-02-25 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 668 | 486,35 | 325 k USD |
| 2026-02-25 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 945 | 486,35 | 460 k USD |
| 2026-02-25 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 620 | 486,35 | 302 k USD |
| 2026-02-25 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 3 k | 486,35 | 1.2 mn USD |
| 2026-02-25 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 489,00 | 1.2 mn USD |
| 2026-02-25 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 486,35 | 898 k USD |
| 2026-02-25 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 260 | 486,35 | 126 k USD |
| 2026-02-25 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 223 | 486,35 | 108 k USD |
| 2026-02-25 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 668 | 486,35 | 325 k USD |
| 2026-02-25 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 945 | 486,35 | 460 k USD |
| 2026-02-25 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 620 | 486,35 | 302 k USD |
| 2026-02-25 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 3 k | 486,35 | 1.2 mn USD |
| 2026-02-25 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 489,00 | 1.2 mn USD |
| 2026-02-25 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 486,35 | 898 k USD |
| 2026-02-25 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 260 | 486,35 | 126 k USD |
| 2026-02-24 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 546 | 485,11 | 265 k USD |
| 2026-02-24 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 485,11 | 789 k USD |
| 2026-02-24 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 485,11 | 555 k USD |
| 2026-02-24 | Bozic Carmen | EVP and CMO | Sell | 1 k | 485,11 | 705 k USD |
| 2026-02-24 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 582 | 485,11 | 282 k USD |
| 2026-02-24 | Kewalramani Reshma | CEO & President | Sell | 5 k | 485,11 | 2.4 mn USD |
| 2026-02-24 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 485,11 | 1.7 mn USD |
| 2026-02-24 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 873 | 485,11 | 424 k USD |
| 2026-02-24 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 485,11 | 736 k USD |
| 2026-02-24 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 485,11 | 789 k USD |
| 2026-02-24 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 546 | 485,11 | 265 k USD |
| 2026-02-24 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 485,11 | 789 k USD |
| 2026-02-24 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 485,11 | 555 k USD |
| 2026-02-24 | Bozic Carmen | EVP and CMO | Sell | 1 k | 485,11 | 705 k USD |
| 2026-02-24 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 582 | 485,11 | 282 k USD |
| 2026-02-24 | Kewalramani Reshma | CEO & President | Sell | 5 k | 485,11 | 2.4 mn USD |
| 2026-02-24 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 873 | 485,11 | 424 k USD |
| 2026-02-24 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 485,11 | 736 k USD |
| 2026-02-24 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 485,11 | 789 k USD |
| 2026-02-24 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 2 k | 485,11 | 846 k USD |
| 2026-02-24 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 485,11 | 1.7 mn USD |
| 2026-02-24 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 2 k | 485,11 | 846 k USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 23 k | 155,57 | 3.7 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 25 k | 187,53 | 4.7 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 920 | 463,91 | 427 k USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 465,05 | 1.3 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 465,80 | 861 k USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 10 k | 467,75 | 4.8 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 20 k | 468,57 | 9.2 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 7 k | 469,61 | 3.4 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 12 k | 470,54 | 5.5 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 471,43 | 2.0 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 23 k | 155,57 | 3.7 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 25 k | 187,53 | 4.7 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 920 | 463,91 | 427 k USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 465,05 | 1.3 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 465,80 | 861 k USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 10 k | 467,75 | 4.8 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 20 k | 468,57 | 9.2 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 7 k | 469,61 | 3.4 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 12 k | 470,54 | 5.5 mn USD |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 471,43 | 2.0 mn USD |
| 2026-02-18 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 638 | 473,68 | 302 k USD |
| 2026-02-18 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 817 | 473,68 | 387 k USD |
| 2026-02-18 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 473,68 | 589 k USD |
| 2026-02-18 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 473,68 | 560 k USD |
| 2026-02-18 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 483,75 | 1.4 mn USD |
| 2026-02-18 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 368 | 473,68 | 174 k USD |
| 2026-02-18 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 638 | 473,68 | 302 k USD |
| 2026-02-18 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 817 | 473,68 | 387 k USD |
| 2026-02-18 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 473,68 | 589 k USD |
| 2026-02-18 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 473,68 | 560 k USD |
| 2026-02-18 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 483,75 | 1.4 mn USD |
| 2026-02-18 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 368 | 473,68 | 174 k USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 598 | 483,75 | 289 k USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 2 k | 489,46 | 762 k USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 483,75 | 740 k USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 489,46 | 994 k USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 4 k | 0,00 | 0 USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 483,75 | 728 k USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 489,46 | 1.2 mn USD |
| 2026-02-17 | Bozic Carmen | EVP and CMO | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | Bozic Carmen | EVP and CMO | Sell | 2 k | 483,75 | 925 k USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 483,75 | 537 k USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 489,46 | 1.2 mn USD |
| 2026-02-17 | Kewalramani Reshma | CEO & President | Buy | 16 k | 0,00 | 0 USD |
| 2026-02-17 | Kewalramani Reshma | CEO & President | Sell | 7 k | 483,75 | 3.2 mn USD |
| 2026-02-17 | LEIDEN JEFFREY M | Executive Chairman | Buy | 8 k | 0,00 | 0 USD |
| 2026-02-17 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1 k | 483,75 | 555 k USD |
| 2026-02-17 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2026-02-17 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 483,75 | 1.0 mn USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 6 k | 0,00 | 0 USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 483,75 | 1.1 mn USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 609 | 489,46 | 298 k USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 598 | 483,75 | 289 k USD |
| 2026-02-17 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 2 k | 489,46 | 762 k USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 483,75 | 740 k USD |
| 2026-02-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 489,46 | 994 k USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 4 k | 0,00 | 0 USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 483,75 | 728 k USD |
| 2026-02-17 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 489,46 | 1.2 mn USD |
| 2026-02-17 | Bozic Carmen | EVP and CMO | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | Bozic Carmen | EVP and CMO | Sell | 2 k | 483,75 | 925 k USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 483,75 | 537 k USD |
| 2026-02-17 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 489,46 | 1.2 mn USD |
| 2026-02-17 | Kewalramani Reshma | CEO & President | Buy | 16 k | 0,00 | 0 USD |
| 2026-02-17 | Kewalramani Reshma | CEO & President | Sell | 7 k | 483,75 | 3.2 mn USD |
| 2026-02-17 | LEIDEN JEFFREY M | Executive Chairman | Buy | 8 k | 0,00 | 0 USD |
| 2026-02-17 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-02-17 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1 k | 483,75 | 555 k USD |
| 2026-02-17 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2026-02-17 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 483,75 | 1.0 mn USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 6 k | 0,00 | 0 USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 483,75 | 1.1 mn USD |
| 2026-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 609 | 489,46 | 298 k USD |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 7 k | 0,00 | 0 USD |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 2 k | 483,75 | 1.1 mn USD |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 7 k | 0,00 | 0 USD |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 2 k | 483,75 | 1.1 mn USD |
| 2026-02-13 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 487,76 | 679 k USD |
| 2026-02-13 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 487,76 | 928 k USD |
| 2026-02-13 | Bhatia Sangeeta N. | Director | Sell | 266 | 500,00 | 133 k USD |
| 2026-02-13 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 3 k | 487,76 | 1.5 mn USD |
| 2026-02-13 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 988 | 499,00 | 493 k USD |
| 2026-02-13 | Bozic Carmen | EVP and CMO | Sell | 4 k | 487,76 | 1.9 mn USD |
| 2026-02-13 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 487,76 | 1.1 mn USD |
| 2026-02-13 | Kewalramani Reshma | CEO & President | Sell | 13 k | 487,76 | 6.4 mn USD |
| 2026-02-13 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 487,76 | 1.1 mn USD |
| 2026-02-13 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 487,76 | 1.7 mn USD |
| 2026-02-13 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 487,76 | 1.9 mn USD |
| 2026-02-13 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 499,99 | 750 k USD |
| 2026-02-13 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 487,76 | 679 k USD |
| 2026-02-13 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 487,76 | 928 k USD |
| 2026-02-13 | Bhatia Sangeeta N. | Director | Sell | 266 | 500,00 | 133 k USD |
| 2026-02-13 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 3 k | 487,76 | 1.5 mn USD |
| 2026-02-13 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 988 | 499,00 | 493 k USD |
| 2026-02-13 | Bozic Carmen | EVP and CMO | Sell | 4 k | 487,76 | 1.9 mn USD |
| 2026-02-13 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 487,76 | 1.1 mn USD |
| 2026-02-13 | Kewalramani Reshma | CEO & President | Sell | 13 k | 487,76 | 6.4 mn USD |
| 2026-02-13 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2 k | 487,76 | 1.1 mn USD |
| 2026-02-13 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 487,76 | 1.7 mn USD |
| 2026-02-13 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 487,76 | 1.9 mn USD |
| 2026-02-13 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 499,99 | 750 k USD |
| 2026-02-13 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 5 k | 487,76 | 2.2 mn USD |
| 2026-02-13 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 5 k | 487,76 | 2.2 mn USD |
| 2026-02-11 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 460,43 | 634 k USD |
| 2026-02-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 460,43 | 806 k USD |
| 2026-02-11 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 460,43 | 886 k USD |
| 2026-02-11 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 460,43 | 931 k USD |
| 2026-02-11 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 466 | 460,43 | 215 k USD |
| 2026-02-11 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 460,43 | 634 k USD |
| 2026-02-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 460,43 | 806 k USD |
| 2026-02-11 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 460,43 | 886 k USD |
| 2026-02-11 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 2 k | 460,43 | 931 k USD |
| 2026-02-11 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 466 | 460,43 | 215 k USD |
| 2026-02-10 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 592 | 468,41 | 277 k USD |
| 2026-02-10 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 872 | 468,41 | 408 k USD |
| 2026-02-10 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 468,41 | 764 k USD |
| 2026-02-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 468,41 | 1.0 mn USD |
| 2026-02-10 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 468,41 | 528 k USD |
| 2026-02-10 | Kewalramani Reshma | CEO & President | Sell | 8 k | 468,41 | 3.9 mn USD |
| 2026-02-10 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1 k | 468,41 | 528 k USD |
| 2026-02-10 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 468,41 | 964 k USD |
| 2026-02-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 468,41 | 1.0 mn USD |
| 2026-02-10 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 592 | 468,41 | 277 k USD |
| 2026-02-10 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 872 | 468,41 | 408 k USD |
| 2026-02-10 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 468,41 | 764 k USD |
| 2026-02-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 468,41 | 1.0 mn USD |
| 2026-02-10 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 1 k | 468,41 | 528 k USD |
| 2026-02-10 | Kewalramani Reshma | CEO & President | Sell | 8 k | 468,41 | 3.9 mn USD |
| 2026-02-10 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1 k | 468,41 | 528 k USD |
| 2026-02-10 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 468,41 | 964 k USD |
| 2026-02-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 468,41 | 1.0 mn USD |
| 2026-02-10 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 3 k | 468,41 | 1.4 mn USD |
| 2026-02-10 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 3 k | 468,41 | 1.4 mn USD |
| 2026-01-22 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2026-01-22 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 6 k | 0,00 | 0 USD |
| 2026-01-22 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Bozic Carmen | EVP and CMO | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Bozic Carmen | EVP and CMO | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Kewalramani Reshma | CEO & President | Buy | 27 k | 0,00 | 0 USD |
| 2026-01-22 | Kewalramani Reshma | CEO & President | Buy | 12 k | 0,00 | 0 USD |
| 2026-01-22 | LEIDEN JEFFREY M | Executive Chairman | Buy | 9 k | 0,00 | 0 USD |
| 2026-01-22 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-01-22 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-01-22 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 6 k | 0,00 | 0 USD |
| 2026-01-22 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Bozic Carmen | EVP and CMO | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Bozic Carmen | EVP and CMO | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Kewalramani Reshma | CEO & President | Buy | 27 k | 0,00 | 0 USD |
| 2026-01-22 | Kewalramani Reshma | CEO & President | Buy | 12 k | 0,00 | 0 USD |
| 2026-01-22 | LEIDEN JEFFREY M | Executive Chairman | Buy | 9 k | 0,00 | 0 USD |
| 2026-01-22 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 5 k | 0,00 | 0 USD |
| 2026-01-22 | McKechnie Duncan | EVP, Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-01-22 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-22 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 9 k | 0,00 | 0 USD |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-22 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2026-01-22 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 9 k | 0,00 | 0 USD |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 4 k | 0,00 | 0 USD |
| 2026-01-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 474,99 | 2.1 mn USD |
| 2026-01-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 474,99 | 2.1 mn USD |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 10 k | 189,38 | 1.8 mn USD |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 10 k | 461,00 | 4.4 mn USD |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO | Buy | 10 k | 189,38 | 1.8 mn USD |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 10 k | 461,00 | 4.4 mn USD |
| 2025-12-04 | LEIDEN JEFFREY M | Executive Chairman | Buy | 1 | 91,05 | 91 USD |
| 2025-12-04 | LEIDEN JEFFREY M | Executive Chairman | Buy | 1 | 91,05 | 91 USD |
| 2025-12-03 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 347 | 449,00 | 156 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Buy | 64 k | 86,52 | 5.5 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 440,40 | 2.0 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 441,26 | 582 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 443,21 | 1.1 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 444,36 | 1.9 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 8 k | 445,56 | 3.5 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 447,05 | 515 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 448,78 | 1.0 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 449,84 | 2.6 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 451,20 | 2.6 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 16 k | 452,20 | 7.1 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 10 k | 453,34 | 4.7 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 455,22 | 942 k USD |
| 2025-12-03 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 449,99 | 2.0 mn USD |
| 2025-12-03 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 347 | 449,00 | 156 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Buy | 64 k | 86,52 | 5.5 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 440,40 | 2.0 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 441,26 | 582 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 443,21 | 1.1 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 444,36 | 1.9 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 8 k | 445,56 | 3.5 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 447,05 | 515 k USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 448,78 | 1.0 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 449,84 | 2.6 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 451,20 | 2.6 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 16 k | 452,20 | 7.1 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 10 k | 453,34 | 4.7 mn USD |
| 2025-12-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 455,22 | 942 k USD |
| 2025-12-03 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 449,99 | 2.0 mn USD |
| 2025-12-03 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 7 k | 451,00 | 3.2 mn USD |
| 2025-12-03 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 7 k | 461,00 | 3.2 mn USD |
| 2025-12-03 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 7 k | 451,00 | 3.2 mn USD |
| 2025-12-03 | WAGNER CHARLES F JR | EVP, CO & FO | Sell | 7 k | 461,00 | 3.2 mn USD |
| 2025-11-19 | CARNEY LLOYD | Director | Sell | 800 | 0,00 | 0 USD |
| 2025-11-19 | CARNEY LLOYD | Director | Sell | 800 | 0,00 | 0 USD |
| 2025-11-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 3 k | 434,58 | 1.1 mn USD |
| 2025-11-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 3 k | 434,58 | 1.1 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Buy | 14 k | 91,05 | 1.3 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Buy | 40 k | 86,52 | 3.4 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 32 k | 440,30 | 14.2 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 21 k | 441,35 | 9.4 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 40 | 442,00 | 18 k USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Buy | 14 k | 91,05 | 1.3 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Buy | 40 k | 86,52 | 3.4 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 32 k | 440,30 | 14.2 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 21 k | 441,35 | 9.4 mn USD |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 40 | 442,00 | 18 k USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Buy | 20 k | 91,05 | 1.8 mn USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 19 k | 440,22 | 8.2 mn USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 441,05 | 512 k USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Buy | 20 k | 91,05 | 1.8 mn USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 19 k | 440,22 | 8.2 mn USD |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 441,05 | 512 k USD |
| 2025-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 694 | 404,21 | 281 k USD |
| 2025-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 694 | 404,21 | 281 k USD |
| 2025-10-01 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 400,00 | 504 k USD |
| 2025-10-01 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1 k | 400,00 | 504 k USD |
| 2025-08-27 | Bhatia Sangeeta N. | Director | Sell | 266 | 386,69 | 103 k USD |
| 2025-08-27 | Bhatia Sangeeta N. | Director | Sell | 266 | 386,69 | 103 k USD |
| 2025-08-06 | Kewalramani Reshma | CEO & President | Buy | 4 k | 389,08 | 1.7 mn USD |
| 2025-08-06 | Kewalramani Reshma | CEO & President | Buy | 6 k | 389,95 | 2.2 mn USD |
| 2025-08-06 | SACHS BRUCE I | Director | Buy | 2 k | 389,36 | 636 k USD |
| 2025-08-06 | SACHS BRUCE I | Director | Buy | 3 k | 389,84 | 1.3 mn USD |
| 2025-08-06 | SACHS BRUCE I | Director | Buy | 2 k | 389,36 | 636 k USD |
| 2025-08-06 | SACHS BRUCE I | Director | Buy | 3 k | 389,84 | 1.3 mn USD |
| 2025-08-06 | Kewalramani Reshma | CEO & President | Buy | 4 k | 389,08 | 1.7 mn USD |
| 2025-08-06 | Kewalramani Reshma | CEO & President | Buy | 6 k | 389,95 | 2.2 mn USD |
| 2025-07-01 | Arbuckle Stuart A | EVP, COO | Sell | 37 k | 450,23 | 16.8 mn USD |
| 2025-07-01 | Arbuckle Stuart A | EVP, COO | Sell | 37 k | 450,23 | 16.8 mn USD |
| 2025-05-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 52 | 424,69 | 22 k USD |
| 2025-05-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 52 | 424,69 | 22 k USD |
| 2025-05-13 | Arbuckle Stuart A | EVP, COO | Buy | 38 k | 0,00 | 0 USD |
| 2025-05-13 | Arbuckle Stuart A | EVP, COO | Buy | 38 k | 0,00 | 0 USD |
| 2025-05-02 | Bhatia Sangeeta N. | Director | Sell | 400 | 505,86 | 202 k USD |
| 2025-05-02 | Bhatia Sangeeta N. | Director | Sell | 400 | 505,86 | 202 k USD |
| 2025-05-01 | Bhatia Sangeeta N. | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | CARNEY LLOYD | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Garber Alan M | Director | Buy | 398 | 0,00 | 0 USD |
| 2025-05-01 | MCKENZIE DIANA | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2025-05-01 | Schneider Jennifer | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Thornberry Nancy | Director | Buy | 398 | 0,00 | 0 USD |
| 2025-05-01 | Upadhyay Suketu | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Upadhyay Suketu | Director | Sell | 1 k | – | – |
| 2025-05-01 | Bhatia Sangeeta N. | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | CARNEY LLOYD | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Garber Alan M | Director | Buy | 398 | 0,00 | 0 USD |
| 2025-05-01 | MCKENZIE DIANA | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2025-05-01 | Schneider Jennifer | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Thornberry Nancy | Director | Buy | 398 | 0,00 | 0 USD |
| 2025-05-01 | Upadhyay Suketu | Director | Buy | 796 | 0,00 | 0 USD |
| 2025-05-01 | Upadhyay Suketu | Director | Sell | 1 k | – | – |
| 2025-03-13 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 510,00 | 1.6 mn USD |
| 2025-03-13 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 510,00 | 1.6 mn USD |
| 2025-03-10 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 500,00 | 1.6 mn USD |
| 2025-03-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 499,99 | 1.6 mn USD |
| 2025-03-10 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 500,00 | 1.6 mn USD |
| 2025-03-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 499,99 | 1.6 mn USD |
| 2025-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 500,00 | 1.6 mn USD |
| 2025-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 500,00 | 1.6 mn USD |
| 2025-03-04 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 485,49 | 2.0 mn USD |
| 2025-03-04 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 485,49 | 2.0 mn USD |
| 2025-03-03 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 490,00 | 1.6 mn USD |
| 2025-03-03 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 3 k | 490,00 | 1.6 mn USD |
| 2025-02-27 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 1 k | 480,00 | 611 k USD |
| 2025-02-27 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 3 k | 475,34 | 1.3 mn USD |
| 2025-02-27 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 530 | 475,34 | 252 k USD |
| 2025-02-27 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 1 k | 480,00 | 611 k USD |
| 2025-02-27 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 3 k | 475,34 | 1.3 mn USD |
| 2025-02-27 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 530 | 475,34 | 252 k USD |
| 2025-02-26 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 6 k | 479,61 | 2.9 mn USD |
| 2025-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 479,61 | 595 k USD |
| 2025-02-26 | Arbuckle Stuart A | EVP, COO | Sell | 7 k | 479,61 | 3.4 mn USD |
| 2025-02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 479,61 | 1.2 mn USD |
| 2025-02-26 | Bozic Carmen | EVP and CMO | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-26 | Kewalramani Reshma | CEO & President | Sell | 14 k | 479,61 | 6.8 mn USD |
| 2025-02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 479,61 | 1.8 mn USD |
| 2025-02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-26 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 6 k | 479,61 | 2.9 mn USD |
| 2025-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 479,61 | 595 k USD |
| 2025-02-26 | Arbuckle Stuart A | EVP, COO | Sell | 7 k | 479,61 | 3.4 mn USD |
| 2025-02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 479,61 | 1.2 mn USD |
| 2025-02-26 | Bozic Carmen | EVP and CMO | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-26 | Kewalramani Reshma | CEO & President | Sell | 14 k | 479,61 | 6.8 mn USD |
| 2025-02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 479,61 | 1.8 mn USD |
| 2025-02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-26 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-26 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 5 k | 479,61 | 2.4 mn USD |
| 2025-02-25 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 848 | 480,95 | 408 k USD |
| 2025-02-25 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 884 | 480,95 | 425 k USD |
| 2025-02-25 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 480,95 | 850 k USD |
| 2025-02-25 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 354 | 480,95 | 170 k USD |
| 2025-02-25 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 848 | 480,95 | 408 k USD |
| 2025-02-25 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 884 | 480,95 | 425 k USD |
| 2025-02-25 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 480,95 | 850 k USD |
| 2025-02-25 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 354 | 480,95 | 170 k USD |
| 2025-02-24 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 4 k | 483,28 | 1.9 mn USD |
| 2025-02-24 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 828 | 483,28 | 400 k USD |
| 2025-02-24 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 483,28 | 2.3 mn USD |
| 2025-02-24 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 483,28 | 800 k USD |
| 2025-02-24 | Bozic Carmen | EVP and CMO | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-24 | Kewalramani Reshma | CEO & President | Sell | 9 k | 483,28 | 4.5 mn USD |
| 2025-02-24 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 483,28 | 1.2 mn USD |
| 2025-02-24 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-24 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 4 k | 483,28 | 1.9 mn USD |
| 2025-02-24 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 828 | 483,28 | 400 k USD |
| 2025-02-24 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 483,28 | 2.3 mn USD |
| 2025-02-24 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 483,28 | 800 k USD |
| 2025-02-24 | Bozic Carmen | EVP and CMO | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-24 | Kewalramani Reshma | CEO & President | Sell | 9 k | 483,28 | 4.5 mn USD |
| 2025-02-24 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 483,28 | 1.2 mn USD |
| 2025-02-24 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 483,28 | 1.6 mn USD |
| 2025-02-20 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 1 k | 480,00 | 533 k USD |
| 2025-02-20 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 1 k | 480,00 | 533 k USD |
| 2025-02-18 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 671 | 455,06 | 305 k USD |
| 2025-02-18 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 455,06 | 754 k USD |
| 2025-02-18 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 244 | 455,06 | 111 k USD |
| 2025-02-18 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 671 | 455,06 | 305 k USD |
| 2025-02-18 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 455,06 | 754 k USD |
| 2025-02-18 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 244 | 455,06 | 111 k USD |
| 2025-02-14 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-14 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 564 | 463,46 | 261 k USD |
| 2025-02-14 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 463,46 | 1.3 mn USD |
| 2025-02-14 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 463,46 | 709 k USD |
| 2025-02-14 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 463,46 | 697 k USD |
| 2025-02-14 | Bozic Carmen | EVP and CMO | Sell | 2 k | 463,46 | 886 k USD |
| 2025-02-14 | Kewalramani Reshma | CEO & President | Sell | 7 k | 463,46 | 3.0 mn USD |
| 2025-02-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 463,46 | 2.8 mn USD |
| 2025-02-14 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 463,46 | 991 k USD |
| 2025-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-14 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-14 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 564 | 463,46 | 261 k USD |
| 2025-02-14 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 463,46 | 1.3 mn USD |
| 2025-02-14 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 463,46 | 709 k USD |
| 2025-02-14 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 463,46 | 697 k USD |
| 2025-02-14 | Bozic Carmen | EVP and CMO | Sell | 2 k | 463,46 | 886 k USD |
| 2025-02-14 | Kewalramani Reshma | CEO & President | Sell | 7 k | 463,46 | 3.0 mn USD |
| 2025-02-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6 k | 463,46 | 2.8 mn USD |
| 2025-02-14 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 463,46 | 991 k USD |
| 2025-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-14 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-14 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 2 k | 463,46 | 1.1 mn USD |
| 2025-02-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 450,83 | 1.1 mn USD |
| 2025-02-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 450,83 | 1.1 mn USD |
| 2025-02-12 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 5 k | 0,00 | 0 USD |
| 2025-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | Arbuckle Stuart A | EVP, COO | Buy | 8 k | 0,00 | 0 USD |
| 2025-02-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 4 k | 0,00 | 0 USD |
| 2025-02-12 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | Kewalramani Reshma | CEO & President | Buy | 19 k | 0,00 | 0 USD |
| 2025-02-12 | LEIDEN JEFFREY M | Executive Chairman | Buy | 7 k | 0,00 | 0 USD |
| 2025-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Buy | 5 k | 0,00 | 0 USD |
| 2025-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | Arbuckle Stuart A | EVP, COO | Buy | 8 k | 0,00 | 0 USD |
| 2025-02-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 4 k | 0,00 | 0 USD |
| 2025-02-12 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | Kewalramani Reshma | CEO & President | Buy | 19 k | 0,00 | 0 USD |
| 2025-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | LEIDEN JEFFREY M | Executive Chairman | Buy | 7 k | 0,00 | 0 USD |
| 2025-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 6 k | 0,00 | 0 USD |
| 2025-02-12 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 7 k | 0,00 | 0 USD |
| 2025-02-11 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 459,83 | 633 k USD |
| 2025-02-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 459,83 | 803 k USD |
| 2025-02-11 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 3 k | 459,87 | 1.6 mn USD |
| 2025-02-11 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 310 | 459,83 | 143 k USD |
| 2025-02-11 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 459,83 | 633 k USD |
| 2025-02-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 459,83 | 803 k USD |
| 2025-02-11 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 3 k | 459,87 | 1.6 mn USD |
| 2025-02-11 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 310 | 459,83 | 143 k USD |
| 2025-02-10 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 591 | 467,98 | 277 k USD |
| 2025-02-10 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 467,98 | 1.5 mn USD |
| 2025-02-10 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 876 | 467,98 | 410 k USD |
| 2025-02-10 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 467,98 | 764 k USD |
| 2025-02-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | Kewalramani Reshma | CEO & President | Sell | 8 k | 467,98 | 3.9 mn USD |
| 2025-02-10 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 467,98 | 962 k USD |
| 2025-02-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 591 | 467,98 | 277 k USD |
| 2025-02-10 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 467,98 | 1.5 mn USD |
| 2025-02-10 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 876 | 467,98 | 410 k USD |
| 2025-02-10 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 467,98 | 764 k USD |
| 2025-02-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | Kewalramani Reshma | CEO & President | Sell | 8 k | 467,98 | 3.9 mn USD |
| 2025-02-10 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 467,98 | 962 k USD |
| 2025-02-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 467,98 | 1.0 mn USD |
| 2025-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 467,98 | 1.2 mn USD |
| 2025-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 467,98 | 1.2 mn USD |
| 2024-11-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 15 | 478,56 | 7 k USD |
| 2024-11-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 15 | 478,56 | 7 k USD |
| 2024-11-11 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 518,27 | 1.6 mn USD |
| 2024-11-11 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 518,27 | 1.6 mn USD |
| 2024-11-08 | Kewalramani Reshma | CEO & President | Sell | 15 k | 515,00 | 7.8 mn USD |
| 2024-11-08 | Kewalramani Reshma | CEO & President | Sell | 15 k | 515,00 | 7.8 mn USD |
| 2024-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 999 | 461,66 | 461 k USD |
| 2024-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 999 | 461,66 | 461 k USD |
| 2024-10-01 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 630 | 466,84 | 294 k USD |
| 2024-10-01 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 630 | 466,84 | 294 k USD |
| 2024-08-30 | Bhatia Sangeeta N. | Director | Buy | 646 | 152,74 | 99 k USD |
| 2024-08-30 | Bhatia Sangeeta N. | Director | Sell | 646 | 500,00 | 323 k USD |
| 2024-08-30 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 499,00 | 1.9 mn USD |
| 2024-08-30 | Bhatia Sangeeta N. | Director | Buy | 646 | 152,74 | 99 k USD |
| 2024-08-30 | Bhatia Sangeeta N. | Director | Sell | 646 | 500,00 | 323 k USD |
| 2024-08-30 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 499,00 | 1.9 mn USD |
| 2024-08-08 | Bhatia Sangeeta N. | Director | Buy | 1 k | 152,74 | 197 k USD |
| 2024-08-08 | Bhatia Sangeeta N. | Director | Sell | 1 k | 466,29 | 602 k USD |
| 2024-08-08 | Bhatia Sangeeta N. | Director | Buy | 1 k | 152,74 | 197 k USD |
| 2024-08-08 | Bhatia Sangeeta N. | Director | Sell | 1 k | 466,29 | 602 k USD |
| 2024-08-07 | Bozic Carmen | EVP and CMO | Sell | 2 k | 476,75 | 1.1 mn USD |
| 2024-08-07 | Bozic Carmen | EVP and CMO | Sell | 2 k | 476,75 | 1.1 mn USD |
| 2024-08-01 | SACHS BRUCE I | Director | Buy | 5 k | 125,71 | 666 k USD |
| 2024-08-01 | SACHS BRUCE I | Director | Sell | 5 k | 508,00 | 2.7 mn USD |
| 2024-08-01 | SACHS BRUCE I | Director | Buy | 5 k | 125,71 | 666 k USD |
| 2024-08-01 | SACHS BRUCE I | Director | Sell | 5 k | 508,00 | 2.7 mn USD |
| 2024-07-30 | Kewalramani Reshma | CEO & President | Sell | 15 k | 505,00 | 7.7 mn USD |
| 2024-07-30 | Kewalramani Reshma | CEO & President | Sell | 15 k | 505,00 | 7.7 mn USD |
| 2024-07-24 | Bozic Carmen | EVP and CMO | Sell | 2 k | 488,46 | 1.1 mn USD |
| 2024-07-24 | Bozic Carmen | EVP and CMO | Sell | 2 k | 488,46 | 1.1 mn USD |
| 2024-07-22 | Kewalramani Reshma | CEO & President | Sell | 15 k | 497,00 | 7.6 mn USD |
| 2024-07-22 | Kewalramani Reshma | CEO & President | Sell | 15 k | 497,00 | 7.6 mn USD |
| 2024-07-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 487,34 | 1.1 mn USD |
| 2024-07-10 | Bozic Carmen | EVP and CMO | Sell | 2 k | 487,34 | 1.1 mn USD |
| 2024-06-26 | Bozic Carmen | EVP and CMO | Sell | 2 k | 471,72 | 1.1 mn USD |
| 2024-06-26 | Bozic Carmen | EVP and CMO | Sell | 2 k | 471,72 | 1.1 mn USD |
| 2024-06-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 7 k | 478,00 | 3.5 mn USD |
| 2024-06-12 | Bozic Carmen | EVP and CMO | Sell | 2 k | 478,00 | 1.1 mn USD |
| 2024-06-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 7 k | 478,00 | 3.5 mn USD |
| 2024-06-12 | Bozic Carmen | EVP and CMO | Sell | 2 k | 478,00 | 1.1 mn USD |
| 2024-06-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 7 k | 481,96 | 3.3 mn USD |
| 2024-06-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 7 k | 481,96 | 3.3 mn USD |
| 2024-06-05 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 5 k | 0,00 | 0 USD |
| 2024-06-05 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 5 k | 0,00 | 0 USD |
| 2024-06-03 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 460,00 | 1.0 mn USD |
| 2024-06-03 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 460,00 | 1.0 mn USD |
| 2024-06-03 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 460,00 | 1.5 mn USD |
| 2024-06-03 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 460,00 | 1.5 mn USD |
| 2024-05-31 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 445,00 | 1.0 mn USD |
| 2024-05-31 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 445,00 | 1.0 mn USD |
| 2024-05-30 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 439,11 | 1.0 mn USD |
| 2024-05-30 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 439,11 | 1.0 mn USD |
| 2024-05-29 | Bozic Carmen | EVP and CMO | Sell | 2 k | 445,56 | 1.0 mn USD |
| 2024-05-29 | Bozic Carmen | EVP and CMO | Sell | 2 k | 445,56 | 1.0 mn USD |
| 2024-05-28 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 454,79 | 1.5 mn USD |
| 2024-05-28 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 454,79 | 1.5 mn USD |
| 2024-05-24 | Kewalramani Reshma | CEO & President | Buy | 2 k | 187,53 | 293 k USD |
| 2024-05-24 | Kewalramani Reshma | CEO & President | Sell | 2 k | 457,00 | 715 k USD |
| 2024-05-24 | Kewalramani Reshma | CEO & President | Buy | 2 k | 187,53 | 293 k USD |
| 2024-05-24 | Kewalramani Reshma | CEO & President | Sell | 2 k | 457,00 | 715 k USD |
| 2024-05-22 | SACHS BRUCE I | Director | Buy | 7 k | 93,51 | 661 k USD |
| 2024-05-22 | SACHS BRUCE I | Director | Sell | 7 k | 448,00 | 3.2 mn USD |
| 2024-05-22 | SACHS BRUCE I | Director | Buy | 7 k | 93,51 | 661 k USD |
| 2024-05-22 | SACHS BRUCE I | Director | Sell | 7 k | 448,00 | 3.2 mn USD |
| 2024-05-20 | Kewalramani Reshma | CEO & President | Sell | 15 k | 447,00 | 6.8 mn USD |
| 2024-05-20 | Kewalramani Reshma | CEO & President | Sell | 15 k | 447,00 | 6.8 mn USD |
| 2024-05-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 54 | 430,93 | 23 k USD |
| 2024-05-15 | Arbuckle Stuart A | EVP, COO | Sell | 69 | 430,93 | 30 k USD |
| 2024-05-15 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 32 | 430,93 | 14 k USD |
| 2024-05-15 | Schneider Jennifer | Director | Buy | 922 | 0,00 | 0 USD |
| 2024-05-15 | Schneider Jennifer | Director | Buy | 922 | 0,00 | 0 USD |
| 2024-05-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | 54 | 430,93 | 23 k USD |
| 2024-05-15 | Arbuckle Stuart A | EVP, COO | Sell | 69 | 430,93 | 30 k USD |
| 2024-05-15 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 32 | 430,93 | 14 k USD |
| 2024-05-14 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 14 k | 0,00 | 0 USD |
| 2024-05-14 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 14 k | 0,00 | 0 USD |
| 2024-05-02 | Bhatia Sangeeta N. | Director | Sell | 467 | 402,95 | 188 k USD |
| 2024-05-02 | Bhatia Sangeeta N. | Director | Sell | 467 | 402,95 | 188 k USD |
| 2024-05-01 | Bhatia Sangeeta N. | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | CARNEY LLOYD | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | MCKENZIE DIANA | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2024-05-01 | Thornberry Nancy | Director | Buy | 501 | 0,00 | 0 USD |
| 2024-05-01 | Upadhyay Suketu | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | Upadhyay Suketu | Director | Sell | 1 k | – | – |
| 2024-05-01 | Bhatia Sangeeta N. | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | CARNEY LLOYD | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | MCKENZIE DIANA | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2024-05-01 | Thornberry Nancy | Director | Buy | 501 | 0,00 | 0 USD |
| 2024-05-01 | Upadhyay Suketu | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-01 | Upadhyay Suketu | Director | Sell | 1 k | – | – |
| 2024-04-02 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 240 | 419,00 | 101 k USD |
| 2024-04-02 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 240 | 419,00 | 101 k USD |
| 2024-04-01 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 225 | 418,10 | 94 k USD |
| 2024-04-01 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 225 | 418,10 | 94 k USD |
| 2024-02-26 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 425,70 | 1.8 mn USD |
| 2024-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 883 | 425,70 | 376 k USD |
| 2024-02-26 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 425,70 | 2.1 mn USD |
| 2024-02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 883 | 425,70 | 376 k USD |
| 2024-02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 425,70 | 1.3 mn USD |
| 2024-02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 354 | 425,70 | 151 k USD |
| 2024-02-26 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 425,70 | 1.8 mn USD |
| 2024-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 883 | 425,70 | 376 k USD |
| 2024-02-26 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 425,70 | 2.1 mn USD |
| 2024-02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 883 | 425,70 | 376 k USD |
| 2024-02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 425,70 | 1.3 mn USD |
| 2024-02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 354 | 425,70 | 151 k USD |
| 2024-02-23 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 431,79 | 1.7 mn USD |
| 2024-02-23 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 828 | 431,79 | 358 k USD |
| 2024-02-23 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 431,79 | 2.0 mn USD |
| 2024-02-23 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 431,79 | 714 k USD |
| 2024-02-23 | Bozic Carmen | EVP and CMO | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-23 | Kewalramani Reshma | CEO & President | Sell | 9 k | 431,79 | 4.1 mn USD |
| 2024-02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 431,79 | 1.1 mn USD |
| 2024-02-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-23 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 431,79 | 1.7 mn USD |
| 2024-02-23 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 828 | 431,79 | 358 k USD |
| 2024-02-23 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 431,79 | 2.0 mn USD |
| 2024-02-23 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 431,79 | 714 k USD |
| 2024-02-23 | Bozic Carmen | EVP and CMO | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-23 | Kewalramani Reshma | CEO & President | Sell | 9 k | 431,79 | 4.1 mn USD |
| 2024-02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 431,79 | 1.1 mn USD |
| 2024-02-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-23 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-23 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 431,79 | 1.4 mn USD |
| 2024-02-21 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 421,77 | 1.3 mn USD |
| 2024-02-21 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 421,77 | 1.5 mn USD |
| 2024-02-21 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 1 k | 421,77 | 507 k USD |
| 2024-02-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 421,77 | 1.3 mn USD |
| 2024-02-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 360 | 421,77 | 152 k USD |
| 2024-02-21 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 421,77 | 1.3 mn USD |
| 2024-02-21 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 421,77 | 1.5 mn USD |
| 2024-02-21 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 1 k | 421,77 | 507 k USD |
| 2024-02-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 421,77 | 1.3 mn USD |
| 2024-02-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 360 | 421,77 | 152 k USD |
| 2024-02-20 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-20 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 420,79 | 1.7 mn USD |
| 2024-02-20 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 420,58 | 1.4 mn USD |
| 2024-02-20 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 420,79 | 2.0 mn USD |
| 2024-02-20 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 1 k | 420,58 | 473 k USD |
| 2024-02-20 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 801 | 420,79 | 337 k USD |
| 2024-02-20 | Bozic Carmen | EVP and CMO | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-20 | Kewalramani Reshma | CEO & President | Sell | 7 k | 420,58 | 3.0 mn USD |
| 2024-02-20 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 420,58 | 1.7 mn USD |
| 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 420,58 | 1.1 mn USD |
| 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 420,79 | 1.8 mn USD |
| 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 420,58 | 1.4 mn USD |
| 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 480 | 420,79 | 202 k USD |
| 2024-02-20 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-20 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 420,79 | 1.7 mn USD |
| 2024-02-20 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 420,58 | 1.4 mn USD |
| 2024-02-20 | Arbuckle Stuart A | EVP, COO | Sell | 5 k | 420,79 | 2.0 mn USD |
| 2024-02-20 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 1 k | 420,58 | 473 k USD |
| 2024-02-20 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 801 | 420,79 | 337 k USD |
| 2024-02-20 | Bozic Carmen | EVP and CMO | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-20 | Kewalramani Reshma | CEO & President | Sell | 7 k | 420,58 | 3.0 mn USD |
| 2024-02-20 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 420,58 | 1.7 mn USD |
| 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 420,58 | 1.1 mn USD |
| 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 4 k | 420,79 | 1.8 mn USD |
| 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 420,58 | 1.4 mn USD |
| 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 480 | 420,79 | 202 k USD |
| 2024-02-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 420,58 | 1.2 mn USD |
| 2024-02-16 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-16 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 424,01 | 1.9 mn USD |
| 2024-02-16 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 424,01 | 636 k USD |
| 2024-02-16 | Bozic Carmen | EVP and CMO | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-16 | Kewalramani Reshma | CEO & President | Sell | 9 k | 424,01 | 4.0 mn USD |
| 2024-02-16 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 424,01 | 1.5 mn USD |
| 2024-02-16 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 424,01 | 1.9 mn USD |
| 2024-02-16 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-16 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 424,01 | 1.9 mn USD |
| 2024-02-16 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 2 k | 424,01 | 636 k USD |
| 2024-02-16 | Bozic Carmen | EVP and CMO | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-16 | Kewalramani Reshma | CEO & President | Sell | 9 k | 424,01 | 4.0 mn USD |
| 2024-02-16 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 424,01 | 1.5 mn USD |
| 2024-02-16 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 4 k | 424,01 | 1.9 mn USD |
| 2024-02-16 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-16 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 4 k | 424,01 | 1.6 mn USD |
| 2024-02-15 | LEIDEN JEFFREY M | Executive Chairman | Sell | 5 k | 419,16 | 2.0 mn USD |
| 2024-02-15 | LEIDEN JEFFREY M | Executive Chairman | Sell | 5 k | 419,16 | 2.0 mn USD |
| 2024-02-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 419,04 | 1.8 mn USD |
| 2024-02-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4 k | 419,04 | 1.8 mn USD |
| 2024-02-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 737 | 419,13 | 309 k USD |
| 2024-02-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 737 | 419,13 | 309 k USD |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 419,22 | 842 k USD |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman | Sell | 647 | 420,39 | 272 k USD |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 419,22 | 842 k USD |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman | Sell | 647 | 420,39 | 272 k USD |
| 2024-02-12 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 420,24 | 1.3 mn USD |
| 2024-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 420,24 | 577 k USD |
| 2024-02-12 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 420,24 | 1.8 mn USD |
| 2024-02-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 913 | 420,24 | 384 k USD |
| 2024-02-12 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 418,77 | 728 k USD |
| 2024-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 420,24 | 1.4 mn USD |
| 2024-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 314 | 420,24 | 132 k USD |
| 2024-02-12 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3 k | 420,24 | 1.3 mn USD |
| 2024-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1 k | 420,24 | 577 k USD |
| 2024-02-12 | Arbuckle Stuart A | EVP, COO | Sell | 4 k | 420,24 | 1.8 mn USD |
| 2024-02-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 913 | 420,24 | 384 k USD |
| 2024-02-12 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 418,77 | 728 k USD |
| 2024-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3 k | 420,24 | 1.4 mn USD |
| 2024-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 314 | 420,24 | 132 k USD |
| 2024-02-09 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 2 k | 422,74 | 887 k USD |
| 2024-02-09 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 591 | 422,74 | 250 k USD |
| 2024-02-09 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 422,74 | 1.3 mn USD |
| 2024-02-09 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 832 | 422,74 | 352 k USD |
| 2024-02-09 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 422,74 | 671 k USD |
| 2024-02-09 | Bozic Carmen | EVP and CMO | Sell | 2 k | 422,74 | 888 k USD |
| 2024-02-09 | Kewalramani Reshma | CEO & President | Sell | 8 k | 422,74 | 3.5 mn USD |
| 2024-02-09 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 422,74 | 855 k USD |
| 2024-02-09 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 422,74 | 888 k USD |
| 2024-02-09 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 2 k | 422,74 | 887 k USD |
| 2024-02-09 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 591 | 422,74 | 250 k USD |
| 2024-02-09 | Arbuckle Stuart A | EVP, COO | Sell | 3 k | 422,74 | 1.3 mn USD |
| 2024-02-09 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 832 | 422,74 | 352 k USD |
| 2024-02-09 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 2 k | 422,74 | 671 k USD |
| 2024-02-09 | Bozic Carmen | EVP and CMO | Sell | 2 k | 422,74 | 888 k USD |
| 2024-02-09 | Kewalramani Reshma | CEO & President | Sell | 8 k | 422,74 | 3.5 mn USD |
| 2024-02-09 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 2 k | 422,74 | 855 k USD |
| 2024-02-09 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2 k | 422,74 | 888 k USD |
| 2024-02-09 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 422,74 | 1.1 mn USD |
| 2024-02-09 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 422,74 | 1.1 mn USD |
| 2024-02-09 | LEIDEN JEFFREY M | Executive Chairman | Sell | 8 k | 422,74 | 3.4 mn USD |
| 2024-02-09 | LEIDEN JEFFREY M | Executive Chairman | Sell | 8 k | 422,74 | 3.4 mn USD |
| 2024-02-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 421,73 | 1.1 mn USD |
| 2024-02-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3 k | 421,73 | 1.1 mn USD |
| 2024-02-07 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-07 | Arbuckle Stuart A | EVP, COO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-07 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 5 k | 0,00 | 0 USD |
| 2024-02-07 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 5 k | 0,00 | 0 USD |
| 2024-02-07 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-07 | Kewalramani Reshma | CEO & President | Buy | 20 k | 0,00 | 0 USD |
| 2024-02-07 | LEIDEN JEFFREY M | Executive Chairman | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-07 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-07 | Arbuckle Stuart A | EVP, COO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-07 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 5 k | 0,00 | 0 USD |
| 2024-02-07 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 5 k | 0,00 | 0 USD |
| 2024-02-07 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-07 | Kewalramani Reshma | CEO & President | Buy | 20 k | 0,00 | 0 USD |
| 2024-02-07 | LEIDEN JEFFREY M | Executive Chairman | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-07 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-07 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-06 | Arbuckle Stuart A | EVP, COO | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-06 | Arbuckle Stuart A | EVP, COO | Buy | 11 k | 0,00 | 0 USD |
| 2024-02-06 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-06 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2024-02-06 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Bozic Carmen | EVP and CMO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Kewalramani Reshma | CEO & President | Buy | 15 k | 0,00 | 0 USD |
| 2024-02-06 | Kewalramani Reshma | CEO & President | Buy | 27 k | 0,00 | 0 USD |
| 2024-02-06 | LEIDEN JEFFREY M | Executive Chairman | Buy | 10 k | 0,00 | 0 USD |
| 2024-02-06 | LEIDEN JEFFREY M | Executive Chairman | Buy | 20 k | 0,00 | 0 USD |
| 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Ambrose Kristen | SVP & Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-06 | Arbuckle Stuart A | EVP, COO | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-06 | Arbuckle Stuart A | EVP, COO | Buy | 11 k | 0,00 | 0 USD |
| 2024-02-06 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-06 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Buy | 4 k | 0,00 | 0 USD |
| 2024-02-06 | Biller Jonathan | EVP and Chief Legal Officer | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Bozic Carmen | EVP and CMO | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Bozic Carmen | EVP and CMO | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Kewalramani Reshma | CEO & President | Buy | 15 k | 0,00 | 0 USD |
| 2024-02-06 | Kewalramani Reshma | CEO & President | Buy | 27 k | 0,00 | 0 USD |
| 2024-02-06 | LEIDEN JEFFREY M | Executive Chairman | Buy | 10 k | 0,00 | 0 USD |
| 2024-02-06 | LEIDEN JEFFREY M | Executive Chairman | Buy | 20 k | 0,00 | 0 USD |
| 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 7 k | 0,00 | 0 USD |
| 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Buy | 8 k | 0,00 | 0 USD |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 9 k | 0,00 | 0 USD |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 6 k | 0,00 | 0 USD |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Buy | 9 k | 0,00 | 0 USD |
| 2024-01-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 7 k | 419,07 | 2.8 mn USD |
| 2024-01-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 7 k | 419,07 | 2.8 mn USD |
| 2024-01-02 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 405,00 | 1.2 mn USD |
| 2024-01-02 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 405,00 | 1.2 mn USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Buy | 3 k | 155,57 | 476 k USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Buy | 14 k | 187,53 | 2.6 mn USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Sell | 17 k | 407,00 | 7.0 mn USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Buy | 3 k | 155,57 | 476 k USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Buy | 14 k | 187,53 | 2.6 mn USD |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Sell | 17 k | 407,00 | 7.0 mn USD |
| 2023-12-13 | Arbuckle Stuart A | EVP, COO | Buy | 9 k | 187,53 | 1.6 mn USD |
| 2023-12-13 | Arbuckle Stuart A | EVP, COO | Sell | 9 k | 399,00 | 3.4 mn USD |
| 2023-12-13 | Kewalramani Reshma | CEO & President | Sell | 5 k | 397,00 | 2.0 mn USD |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 13 k | 399,41 | 5.3 mn USD |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 100 | 400,19 | 40 k USD |
| 2023-12-13 | Arbuckle Stuart A | EVP, COO | Buy | 9 k | 187,53 | 1.6 mn USD |
| 2023-12-13 | Arbuckle Stuart A | EVP, COO | Sell | 9 k | 399,00 | 3.4 mn USD |
| 2023-12-13 | Kewalramani Reshma | CEO & President | Sell | 5 k | 397,00 | 2.0 mn USD |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 13 k | 399,41 | 5.3 mn USD |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 100 | 400,19 | 40 k USD |
| 2023-12-05 | Thornberry Nancy | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-12-05 | Thornberry Nancy | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-11-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 349,88 | 1.0 mn USD |
| 2023-11-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3 k | 349,88 | 1.0 mn USD |
| 2023-11-15 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 19 | 369,92 | 7 k USD |
| 2023-11-14 | Bozic Carmen | EVP and CMO | Sell | 6 k | 380,82 | 2.2 mn USD |
| 2023-11-14 | Bozic Carmen | EVP and CMO | Sell | 6 k | 380,82 | 2.2 mn USD |
| 2023-11-13 | Kewalramani Reshma | CEO & President | Sell | 5 k | 377,00 | 1.9 mn USD |
| 2023-11-13 | Kewalramani Reshma | CEO & President | Sell | 5 k | 377,00 | 1.9 mn USD |
| 2023-11-06 | SACHS BRUCE I | Director | Buy | 11 k | 127,54 | 1.4 mn USD |
| 2023-11-06 | SACHS BRUCE I | Director | Sell | 11 k | 385,00 | 4.3 mn USD |
| 2023-11-06 | SACHS BRUCE I | Director | Buy | 11 k | 127,54 | 1.4 mn USD |
| 2023-11-06 | SACHS BRUCE I | Director | Sell | 11 k | 385,00 | 4.3 mn USD |
| 2023-10-31 | Bozic Carmen | EVP and CMO | Sell | 6 k | 355,92 | 2.0 mn USD |
| 2023-10-31 | Bozic Carmen | EVP and CMO | Sell | 6 k | 355,92 | 2.0 mn USD |
| 2023-10-17 | Bhatia Sangeeta N. | Director | Sell | 243 | 375,00 | 91 k USD |
| 2023-10-17 | Bozic Carmen | EVP and CMO | Sell | 6 k | 373,25 | 2.1 mn USD |
| 2023-10-17 | Bhatia Sangeeta N. | Director | Sell | 243 | 375,00 | 91 k USD |
| 2023-10-17 | Bozic Carmen | EVP and CMO | Sell | 6 k | 373,25 | 2.1 mn USD |
| 2023-10-16 | LEIDEN JEFFREY M | Executive Chairman | Sell | 13 k | 374,00 | 4.8 mn USD |
| 2023-10-16 | LEIDEN JEFFREY M | Executive Chairman | Sell | 13 k | 374,00 | 4.8 mn USD |
| 2023-10-06 | Bhatia Sangeeta N. | Director | Sell | 242 | 360,00 | 87 k USD |
| 2023-10-06 | Bhatia Sangeeta N. | Director | Sell | 242 | 360,00 | 87 k USD |
| 2023-10-05 | Lagarde Michel | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-10-05 | Lagarde Michel | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-10-03 | Bozic Carmen | EVP and CMO | Sell | 6 k | 345,28 | 2.0 mn USD |
| 2023-10-03 | Bozic Carmen | EVP and CMO | Sell | 6 k | 345,28 | 2.0 mn USD |
| 2023-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 610 | 346,76 | 212 k USD |
| 2023-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 610 | 346,76 | 212 k USD |
| 2023-09-29 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 408 | 350,72 | 143 k USD |
| 2023-09-29 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 408 | 350,72 | 143 k USD |
| 2023-09-19 | Bozic Carmen | EVP and CMO | Sell | 6 k | 351,00 | 2.0 mn USD |
| 2023-09-19 | Bozic Carmen | EVP and CMO | Sell | 6 k | 351,00 | 2.0 mn USD |
| 2023-09-05 | Bozic Carmen | EVP and CMO | Sell | 6 k | 352,66 | 2.0 mn USD |
| 2023-09-05 | Bozic Carmen | EVP and CMO | Sell | 6 k | 352,66 | 2.0 mn USD |
| 2023-08-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 355,00 | 888 k USD |
| 2023-08-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 3 k | 355,00 | 888 k USD |
| 2023-08-10 | Kearney Terrence C | Director | Buy | 10 k | 127,54 | 1.3 mn USD |
| 2023-08-10 | Kearney Terrence C | Director | Sell | 10 k | 350,00 | 3.5 mn USD |
| 2023-08-10 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 10 k | 350,00 | 3.5 mn USD |
| 2023-08-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 6 k | 345,79 | 2.0 mn USD |
| 2023-08-10 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 10 k | 350,00 | 3.5 mn USD |
| 2023-08-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 6 k | 345,79 | 2.0 mn USD |
| 2023-08-10 | Kearney Terrence C | Director | Buy | 10 k | 127,54 | 1.3 mn USD |
| 2023-08-10 | Kearney Terrence C | Director | Sell | 10 k | 350,00 | 3.5 mn USD |
| 2023-08-09 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 63 | 345,51 | 22 k USD |
| 2023-08-09 | Bhatia Sangeeta N. | Director | Sell | 242 | 345,51 | 84 k USD |
| 2023-08-09 | Bhatia Sangeeta N. | Director | Sell | 242 | 345,51 | 84 k USD |
| 2023-08-09 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 63 | 345,51 | 22 k USD |
| 2023-07-17 | Kewalramani Reshma | CEO & President | Sell | 8 k | 355,00 | 2.8 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Buy | 11 k | 127,54 | 1.4 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 2 k | 355,54 | 603 k USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 6 k | 356,75 | 2.0 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 4 k | 357,29 | 1.4 mn USD |
| 2023-07-17 | Kewalramani Reshma | CEO & President | Sell | 8 k | 355,00 | 2.8 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Buy | 11 k | 127,54 | 1.4 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 2 k | 355,54 | 603 k USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 6 k | 356,75 | 2.0 mn USD |
| 2023-07-17 | SACHS BRUCE I | Director | Sell | 4 k | 357,29 | 1.4 mn USD |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO | Buy | 9 k | 187,53 | 1.6 mn USD |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO | Sell | 9 k | 349,00 | 3.0 mn USD |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO | Buy | 9 k | 187,53 | 1.6 mn USD |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO | Sell | 9 k | 349,00 | 3.0 mn USD |
| 2023-05-30 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 289 | 329,82 | 95 k USD |
| 2023-05-30 | Arbuckle Stuart A | EVP, COO | Sell | 82 | 329,82 | 27 k USD |
| 2023-05-30 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 289 | 329,82 | 95 k USD |
| 2023-05-30 | Arbuckle Stuart A | EVP, COO | Sell | 82 | 329,82 | 27 k USD |
| 2023-05-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 349,00 | 393 k USD |
| 2023-05-08 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 3 k | 350,00 | 998 k USD |
| 2023-05-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 1 k | 349,00 | 393 k USD |
| 2023-05-08 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 3 k | 350,00 | 998 k USD |
| 2023-05-05 | LEIDEN JEFFREY M | Executive Chairman | Sell | 708 | 349,38 | 247 k USD |
| 2023-05-05 | LEIDEN JEFFREY M | Executive Chairman | Sell | 171 | 350,30 | 60 k USD |
| 2023-05-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 422 | 350,03 | 148 k USD |
| 2023-05-05 | LEIDEN JEFFREY M | Executive Chairman | Sell | 708 | 349,38 | 247 k USD |
| 2023-05-05 | LEIDEN JEFFREY M | Executive Chairman | Sell | 171 | 350,30 | 60 k USD |
| 2023-05-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 422 | 350,03 | 148 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 349,22 | 701 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 350,53 | 631 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 700 | 351,59 | 246 k USD |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2 k | 350,44 | 719 k USD |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 728 | 351,60 | 256 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 349,22 | 701 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 350,53 | 631 k USD |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 700 | 351,59 | 246 k USD |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2 k | 350,44 | 719 k USD |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 728 | 351,60 | 256 k USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 5 k | 349,48 | 1.6 mn USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 350,48 | 527 k USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 300 | 353,18 | 106 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 1 k | 350,32 | 494 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 42 | 351,65 | 15 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 169 | 353,24 | 60 k USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 5 k | 349,48 | 1.6 mn USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2 k | 350,48 | 527 k USD |
| 2023-05-02 | LEIDEN JEFFREY M | Executive Chairman | Sell | 300 | 353,18 | 106 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 1 k | 350,32 | 494 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 42 | 351,65 | 15 k USD |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 169 | 353,24 | 60 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 62 | 345,93 | 21 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 172 | 346,69 | 60 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 120 | 348,16 | 42 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 163 | 349,82 | 57 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 63 | 351,20 | 22 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 62 | 345,93 | 21 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 172 | 346,69 | 60 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 120 | 348,16 | 42 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 163 | 349,82 | 57 k USD |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 63 | 351,20 | 22 k USD |
| 2023-05-01 | Bhatia Sangeeta N. | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | CARNEY LLOYD | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | Garber Alan M | Director | Buy | 584 | 0,00 | 0 USD |
| 2023-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2023-05-01 | MCKENZIE DIANA | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | Upadhyay Suketu | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | Bhatia Sangeeta N. | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | CARNEY LLOYD | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | Garber Alan M | Director | Buy | 584 | 0,00 | 0 USD |
| 2023-05-01 | MCKENZIE DIANA | Director | Sell | 1 k | – | – |
| 2023-05-01 | MCKENZIE DIANA | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-01 | Upadhyay Suketu | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 338,69 | 546 k USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 339,43 | 566 k USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 38 | 340,19 | 13 k USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 338,69 | 546 k USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 2 k | 339,43 | 566 k USD |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 38 | 340,19 | 13 k USD |
| 2023-04-13 | SACHS BRUCE I | Director | Sell | 1 k | 0,00 | 0 USD |
| 2023-04-13 | SACHS BRUCE I | Director | Sell | 1 k | 0,00 | 0 USD |

